Lv6
2404 积分 2026-01-21 加入
Safety, pharmacokinetics, and efficacy of HY-072808 ointment, a novel PDE4 inhibitor, in adolescent and adult patients with mild-to-moderate AD
1个月前
已完结
Evaluating the drug-drug interactions of SHR4640 on repaglinide and midazolam in healthy subjects
1个月前
已完结
Safety, pharmacokinetics, and bioequivalence of vunakizumab injection, a specific dermatitis drug, in healthy Chinese volunteers: an open-label, randomized, two-stage, two-sequence cross-over study
1个月前
已完结
Incorporation of healthy volunteers data on receptor occupancy into a phase II proof‐of‐concept trial using a Bayesian dynamic borrowing design
2个月前
已完结
Discovery of the novel and potent histamine H1 receptor antagonists for treatment of allergic diseases
2个月前
已完结
Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis
3个月前
已完结
BMA‐Mod: A Bayesian model averaging strategy for determining dose‐response relationships in the presence of model uncertainty
3个月前
已完结
A Bayesian design for finding optimal biological dose with mixed types of responses of toxicity and efficacy
3个月前
已完结
Integrative population pharmacokinetic modeling of two BCMA-targeted and one CD19-targeted CAR-T therapies using full Bayesian inference with a student’s t-based M3 censoring approach for robust handling of outliers and BLQ data
3个月前
已关闭
Enhancing pharmacometric modeling with full Bayesian inference and Student’s t-Based M3 Censoring: A simulated population PK study on robust handling of outliers and censored data
3个月前
已关闭
皖公网安备34019202002308
